861012 86 Ruling Active

The tariff classification of Serophene tablets from Israel.

Issued April 8, 1991 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 3004.90.6090

Headings: 3004

Product description

The Serophene tablets contain 50mg of 2-[p-(2-chloro-1,2- diphenylvinyl) phenoxy] triethylamine dihydrogen citrate, also known as clomiphene citrate. It is a synthetic, non-steroidal agent that is ingested orally and may induce ovulation.

CBP rationale

The applicable subheading for the Serophene tablets will be 3004.90.6090, Harmonized Tariff Schedule of the United States (HTS), which provides for medicaments (excluding goods of heading 3002, 3005 or 3006) put up in measured doses, other, other.

Full text

NY 861012 APR 08 1991 CLA-2-30:S:N:N1:238 861012 CATEGORY: Classification TARIFF NO.: 3004.90.6090 Richard M. Wortman Grunfeld, Desiderio, Lebowitz & Silverman 12 East 49th Street New York, NY 10017 RE: The tariff classification of Serophene tablets from Israel. Dear Mr. Wortman: In your letter dated March 1, 1991, on behalf of Serono Laboratories, Inc. you requested a tariff classification ruling. The Serophene tablets contain 50mg of 2-[p-(2-chloro-1,2- diphenylvinyl) phenoxy] triethylamine dihydrogen citrate, also known as clomiphene citrate. It is a synthetic, non-steroidal agent that is ingested orally and may induce ovulation. The applicable subheading for the Serophene tablets will be 3004.90.6090, Harmonized Tariff Schedule of the United States (HTS), which provides for medicaments (excluding goods of heading 3002, 3005 or 3006) put up in measured doses, other, other. The duty rate will be 6.3 percent. Articles classifiable under subheading 3004.90.6090, HTS, which are products of Israel are entitled to duty free treatment under the Generalized System of Preferences (GSP) upon compliance with all applicable regulations. This ruling is being issued under the provisions of Section 177 of the Customs Regulations (19 C.F.R. 177). A copy of this ruling letter should be attached to the entry documents filed at the time this merchandise is imported. If the documents have been filed without a copy, this ruling should be brought to the attention of the Customs officer handling the transaction. Sincerely, Jean F. Maguire Area Director New York Seaport

View original on CBP CROSS →

More rulings on the same tariff codes

802665 November 1, 1994

The tariff classification of five homeopathic remedies, put up for retail sale, from Canada

802668 November 1, 1994

The tariff classification of five homeopathic remedies, put up for retail sale, from Canada

802667 November 1, 1994

The tariff classification of four homeopathic remedies, put up for retail sale, from Canada

802664 November 1, 1994

The tariff classification of five homeopathic remedies, put up for retail sale, from Canada

802756 October 20, 1994

The tariff classification of Ritodrine tablets from Sweden

883361 April 21, 1993

The tariff classification of "Zoloft" (sertraline hydrochloride)capsules; "Glucotrol" (glipizide) tablets; and Glipizide (CAS Reg. No. 29094-61-9), in bulk form, from England, Germany, or Japan

880623 December 16, 1992

The tariff classification of Homeopathic potentized naturalmedicine extracts on a sugar globule from India

872957 May 15, 1992

The tariff classification of porcine or bovine-derived bloodplasma, containing fibronectin, that has been added to a 30% ureasolution and put up for importation in vials, from Switzerland.

867641 October 29, 1991

The tariff classification of opacifying preparations for X-ray examinations, and medicaments, consisting of mixed or unmixedproducts for therapeutic or prophylactic uses, put up in measureddoses or in forms or packings for retail sale, from Australia.

864162 July 17, 1991

The tariff classification of Hetrazan (Diethylcarbamazinecitrate), a drug in bulk and dosage forms, and Caltrate Tablets,a high potency calcium supplement, from England and Australia

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →